117 related articles for article (PubMed ID: 38395391)
1. Ntsr1 contributes to pulmonary hypertension by enhancing endoplasmic reticulum stress via JAK2-STAT3-Thbs1 signaling.
Wei ZX; Cai XX; Fei YD; Wang Q; Hu XL; Li C; Hou JW; Yang YL; Wang YP; Li YG
Transl Res; 2024 Jul; 269():64-75. PubMed ID: 38395391
[TBL] [Abstract][Full Text] [Related]
2. Let-7a-transfected mesenchymal stem cells ameliorate monocrotaline-induced pulmonary hypertension by suppressing pulmonary artery smooth muscle cell growth through STAT3-BMPR2 signaling.
Cheng G; Wang X; Li Y; He L
Stem Cell Res Ther; 2017 Feb; 8(1):34. PubMed ID: 28187784
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of PDCD4 through STAT3/ATF6/autophagy mediates MIF-induced PASMCs proliferation/migration and vascular remodeling.
Chai L; Wang Q; Wang Y; Li D; Zhang Q; Chen Y; Liu J; Chen H; Qiu Y; Shen N; Wang J; Xie X; Li M
Eur J Pharmacol; 2023 Oct; 956():175968. PubMed ID: 37549728
[TBL] [Abstract][Full Text] [Related]
4. Blockade of JAK2 protects mice against hypoxia-induced pulmonary arterial hypertension by repressing pulmonary arterial smooth muscle cell proliferation.
Zhang L; Wang Y; Wu G; Rao L; Wei Y; Yue H; Yuan T; Yang P; Xiong F; Zhang S; Zhou Q; Chen Z; Li J; Mo BW; Zhang H; Xiong W; Wang CY
Cell Prolif; 2020 Feb; 53(2):e12742. PubMed ID: 31943454
[TBL] [Abstract][Full Text] [Related]
5. Critical role for the advanced glycation end-products receptor in pulmonary arterial hypertension etiology.
Meloche J; Courchesne A; Barrier M; Carter S; Bisserier M; Paulin R; Lauzon-Joset JF; Breuils-Bonnet S; Tremblay É; Biardel S; Racine C; Courture C; Bonnet P; Majka SM; Deshaies Y; Picard F; Provencher S; Bonnet S
J Am Heart Assoc; 2013 Jan; 2(1):e005157. PubMed ID: 23525442
[TBL] [Abstract][Full Text] [Related]
6. Interferon regulatory factor 7 inhibits rat vascular smooth muscle cell proliferation and inflammation in monocrotaline-induced pulmonary hypertension.
Deng Y; Guo SL; Li JQ; Xie SS; Zhou YC; Wei B; Wang Q; Wang F
Life Sci; 2021 Jan; 264():118709. PubMed ID: 33152351
[TBL] [Abstract][Full Text] [Related]
7. HMGB2 Release Promotes Pulmonary Hypertension and Predicts Severity and Mortality of Patients With Pulmonary Arterial Hypertension.
Kong D; Liu J; Lu J; Zeng C; Chen H; Duan Z; Yu K; Zheng X; Zou P; Zhou L; Lv Y; Zeng Q; Lu L; Li J; He Y
Arterioscler Thromb Vasc Biol; 2024 Jun; 44(6):e172-e195. PubMed ID: 38572649
[TBL] [Abstract][Full Text] [Related]
8. Calcineurin/NFAT Signaling Modulates Pulmonary Artery Smooth Muscle Cell Proliferation, Migration and Apoptosis in Monocrotaline-Induced Pulmonary Arterial Hypertension Rats.
He RL; Wu ZJ; Liu XR; Gui LX; Wang RX; Lin MJ
Cell Physiol Biochem; 2018; 49(1):172-189. PubMed ID: 30134231
[TBL] [Abstract][Full Text] [Related]
9. Lipocalin-2 Promotes Endoplasmic Reticulum Stress and Proliferation by Augmenting Intracellular Iron in Human Pulmonary Arterial Smooth Muscle Cells.
Wang G; Liu S; Wang L; Meng L; Cui C; Zhang H; Hu S; Ma N; Wei Y
Int J Biol Sci; 2017; 13(2):135-144. PubMed ID: 28255266
[TBL] [Abstract][Full Text] [Related]
10. Neutralization of CXCL12 attenuates established pulmonary hypertension in rats.
Bordenave J; Thuillet R; Tu L; Phan C; Cumont A; Marsol C; Huertas A; Savale L; Hibert M; Galzi JL; Bonnet D; Humbert M; Frossard N; Guignabert C
Cardiovasc Res; 2020 Mar; 116(3):686-697. PubMed ID: 31173066
[TBL] [Abstract][Full Text] [Related]
11. PAR-2 inhibition reverses experimental pulmonary hypertension.
Kwapiszewska G; Markart P; Dahal BK; Kojonazarov B; Marsh LM; Schermuly RT; Taube C; Meinhardt A; Ghofrani HA; Steinhoff M; Seeger W; Preissner KT; Olschewski A; Weissmann N; Wygrecka M
Circ Res; 2012 Apr; 110(9):1179-91. PubMed ID: 22461388
[TBL] [Abstract][Full Text] [Related]
12. Xbp1s-Ddit3 promotes MCT-induced pulmonary hypertension.
Jiang H; Ding D; He Y; Li X; Xu Y; Liu X
Clin Sci (Lond); 2021 Nov; 135(21):2467-2481. PubMed ID: 34676402
[TBL] [Abstract][Full Text] [Related]
13. TRB3 mediates vascular remodeling by activating the MAPK signaling pathway in hypoxic pulmonary hypertension.
Cao X; Fang X; Guo M; Li X; He Y; Xie M; Xu Y; Liu X
Respir Res; 2021 Dec; 22(1):312. PubMed ID: 34906150
[TBL] [Abstract][Full Text] [Related]
14. Critical role of VGLL4 in the regulation of chronic normobaric hypoxia-induced pulmonary hypertension in mice.
Tian Q; Fan X; Ma J; Li D; Han Y; Yin X; Wang H; Huang T; Wang Z; Shentu Y; Xue F; Du C; Wang Y; Mao S; Fan J; Gong Y
FASEB J; 2021 Aug; 35(8):e21822. PubMed ID: 34314061
[TBL] [Abstract][Full Text] [Related]
15. TRPC4 aggravates hypoxic pulmonary hypertension by promoting pulmonary endothelial cell apoptosis.
Yang L; Peng Z; Gong F; Yan W; Shi Y; Li H; Zhou C; Yao H; Yuan M; Yu F; Feng L; Wan N; Liu G
Free Radic Biol Med; 2024 Jul; 219():141-152. PubMed ID: 38636714
[TBL] [Abstract][Full Text] [Related]
16. Exosomes derived from mesenchymal stromal cells exert a therapeutic effect on hypoxia-induced pulmonary hypertension by modulating the YAP1/SPP1 signaling pathway.
Chen YX; Deng ZH; Xue-Gao ; Qiang-Du ; Juan-Yin ; Chen GH; Li JG; Zhao YM; Zhang HT; Zhang GX; Qian JX
Biomed Pharmacother; 2023 Dec; 168():115816. PubMed ID: 37918254
[TBL] [Abstract][Full Text] [Related]
17. Canagliflozin inhibits PASMCs proliferation via regulating SGLT1/AMPK signaling and attenuates artery remodeling in MCT-induced pulmonary arterial hypertension.
Chen X; Yu X; Lian G; Tang H; Yan Y; Gao G; Huang B; Luo L; Xie L
Biomed Pharmacother; 2024 May; 174():116505. PubMed ID: 38574614
[TBL] [Abstract][Full Text] [Related]
18. H
Wu J; Pan W; Wang C; Dong H; Xing L; Hou J; Fang S; Li H; Yang F; Yu B
Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31239370
[No Abstract] [Full Text] [Related]
19. Inhibition of miR-361-5p suppressed pulmonary artery smooth muscle cell survival and migration by targeting ABCA1 and inhibiting the JAK2/STAT3 pathway.
Zhang X; Shao R; Gao W; Sun G; Liu Y; Fa X
Exp Cell Res; 2018 Feb; 363(2):255-261. PubMed ID: 29339076
[TBL] [Abstract][Full Text] [Related]
20. LncRNA-SMILR modulates RhoA/ROCK signaling by targeting miR-141 to regulate vascular remodeling in pulmonary arterial hypertension.
Lei S; Peng F; Li ML; Duan WB; Peng CQ; Wu SJ
Am J Physiol Heart Circ Physiol; 2020 Aug; 319(2):H377-H391. PubMed ID: 32559140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
